Overview
Hereditary acrokeratotic poikiloderma, also known as Weary-Kindler syndrome or Kindler syndrome (though distinct from the more commonly referenced Kindler syndrome associated with FERMT1 mutations), is a rare inherited skin disorder characterized by the combination of poikiloderma and acrokeratosis. Poikiloderma refers to a pattern of skin changes that includes areas of increased and decreased pigmentation (hyper- and hypopigmentation), skin atrophy (thinning), and telangiectasia (small dilated blood vessels visible on the skin surface). Acrokeratosis refers to thickening of the skin (keratosis) on the extremities, particularly the hands and feet. These skin findings typically develop in early childhood and may progressively worsen over time. The condition primarily affects the integumentary system (skin). Key clinical features include widespread poikilodermatous changes on sun-exposed and non-exposed areas, keratotic (thickened) papules and plaques on the dorsal hands, feet, elbows, and knees, and photosensitivity in some patients. Additional features may include nail dystrophy, mild blistering in infancy, and mucosal involvement. The skin changes can be cosmetically significant and may cause discomfort. There is no specific curative treatment for hereditary acrokeratotic poikiloderma. Management is primarily supportive and symptomatic, including sun protection, emollients, and careful monitoring of skin lesions. Retinoids have been tried in some cases with variable results. Regular dermatologic follow-up is recommended to monitor for any complications.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Hereditary acrokeratotic poikiloderma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary acrokeratotic poikiloderma at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hereditary acrokeratotic poikiloderma.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary acrokeratotic poikiloderma.
Community
No community posts yet. Be the first to share your experience with Hereditary acrokeratotic poikiloderma.
Start the conversation →Latest news about Hereditary acrokeratotic poikiloderma
No recent news articles for Hereditary acrokeratotic poikiloderma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary acrokeratotic poikiloderma
What is Hereditary acrokeratotic poikiloderma?
Hereditary acrokeratotic poikiloderma, also known as Weary-Kindler syndrome or Kindler syndrome (though distinct from the more commonly referenced Kindler syndrome associated with FERMT1 mutations), is a rare inherited skin disorder characterized by the combination of poikiloderma and acrokeratosis. Poikiloderma refers to a pattern of skin changes that includes areas of increased and decreased pigmentation (hyper- and hypopigmentation), skin atrophy (thinning), and telangiectasia (small dilated blood vessels visible on the skin surface). Acrokeratosis refers to thickening of the skin (keratosi
How is Hereditary acrokeratotic poikiloderma inherited?
Hereditary acrokeratotic poikiloderma follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hereditary acrokeratotic poikiloderma typically begin?
Typical onset of Hereditary acrokeratotic poikiloderma is childhood. Age of onset can vary across affected individuals.